Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cstone Pharmaceuticals

Clinical trials sponsored by Cstone Pharmaceuticals, explained in plain language.

CStone Pharmaceuticals 2616 HKEX

A biopharmaceutical company focused on developing and commercializing innovative cancer therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hope for rare blood cancer: drug combo targets relapsed lymphoma

Disease control Not yet recruiting

This study tests whether adding the drug sugemalimab to standard chemotherapy can help adults with a rare type of blood cancer (NK/T-cell lymphoma) that has returned or stopped responding to previous treatment. About 150 participants will receive either the new combination or a p…

Phase: PHASE3 • Sponsor: CStone Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC